Neural Correlates of Sensory Phenomena in Tourette Syndrome

Tourette Syndrome Clinical Trial

Official title:

Neural Correlates of Sensory Phenomena in Tourette Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03914664
• Other study ID #: NCoSPTS
• Status: Recruiting
• Start date: July 20, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: January 2024
• Source: Vanderbilt University Medical Center
• Contact: David A Isaacs, MD
• Phone: 615-875-7394
• Email: david.a.isaacs[@]vumc.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The most pervasive sensory manifestation of TS is sensory over-responsivity (SOR). SOR is defined as excessive behavioral response to commonplace environmental stimuli. SOR is an integral but poorly understood facet of the TS phenotype, one intertwined with core elements of the disorder and worse QOL. This proposal seeks to clarify the mechanistic bases of SOR in TS. Adults with with TS will be recruited 1) to complete a standardized clinical symptom assessment battery and 2) to undergo electroencephalogram (EEG), autonomic, and audio-visual monitoring during tactile and auditory stimuli paradigms, as well as at rest.

Description:

Tourette syndrome (TS) is a multifaceted disorder that affects 0.6-1% of the global population. Across the lifespan, individuals with TS suffer worse quality of life (QOL) than the general population. While tics are the defining feature of TS, it is the widespread psychiatric and sensory symptoms that exert greater impact on QOL: more than 85% of individuals with TS are diagnosed with a psychiatric disorder, and 90% experience distressing sensory symptoms. The latest TS disease models and practice guidelines account for common psychiatric symptoms, but sensory symptoms remain under-recognized and under-studied. Progress in understanding and treating TS requires deepening insight into the disorder's sensory dimension.

The most pervasive sensory manifestation of TS is sensory over-responsivity (SOR). SOR is defined as excessive behavioral response to commonplace environmental stimuli. SOR is associated with avoidant behavior and functional impairment. More than 50% of children and 80% of adults with TS report SOR. Across age groups, SOR is positively correlated with severity of tics and psychiatric symptoms and negatively correlated with QOL. Thus, SOR is an integral facet of the TS phenotype, one intertwined with core elements of the disorder and worse QOL. This proposal seeks to clarify the mechanistic bases of SOR in TS (Aims 1 and 2).

Enhanced understanding of SOR's neurobiological basis is crucial to a more complete knowledge of TS pathophysiology. Two neurophysiologic mechanisms are implicated in SOR: sensory gating impairment and autonomic hyperarousal. Sensory gating is the physiologic process whereby redundant environmental stimuli are filtered out in the early stages of perception. Impairment of sensory gating gives rise to altered sensory perception. Autonomic hyperarousal is a state of excessive sympathetic tone and/or reduced parasympathetic tone, which hampers behavioral adaptation to sensory input. In TS, multiple lines of evidence suggest both sensory gating and autonomic function are impaired. However, prior investigations have suffered from methodologic limitations and have not examined the link between neurophysiologic dysfunction and sensory symptoms.

Aim 1. Identify an electroencephalographic (EEG) signature of SOR in TS. Hypotheses: (1a) relative to healthy controls, TS adults exhibit impaired sensory gating; (1b) extent of impaired sensory gating in TS correlates with degree of SOR. We will recruit 60 TS adults and 60 age- and sex-matched healthy controls to complete rating scales for SOR, psychiatric symptoms, and tics. Subjects will then be monitored on dense-array scalp EEG during sequential auditory and tactile sensory gating paradigms.

Aim 2. Identify an autonomic signature of SOR in TS. Hypotheses: (2a) relative to healthy controls, TS adults exhibit autonomic hyperarousal in response to non-aversive sensory stimuli; (2b) extent of autonomic hyperarousal correlates with SOR severity in TS. Heart rate and electrodermal activity will be monitored during the Aim 1 sensory gating paradigms and during a 10-minute rest period. Heart rate variability and electrodermal activity will serve as indices of parasympathetic and sympathetic activity, respectively.

Impact: Results will clarify the extent of sensory gating impairment in TS, the nature of autonomic dysfunction in TS, and the clinical correlates of neurophysiologic dysfunction in TS.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: December 31, 2024
• Est. primary completion date: May 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria for TS arm:

• Diagnosis of Tourette syndrome or other chronic tic disorder

• = 18 years of age

• Ability to complete survey instruments

• English fluency (given that all scales are validated in English)

Exclusion criteria for TS arm:

• Known diagnosis of autism spectrum disorder, developmental delay, cerebral palsy, other significant neurologic disease, schizophrenia, or psychotic disorders will be excluded, in order to lessen potentially confounding factors.

(Note: Patients with OCD, ADHD, anxiety, and/or depression will be permitted, given that these diagnoses are widely prevalent in the adult TS population.)

• Use of anti-seizure medications, stimulants, or other psychotropic medications known to alter EEG signal

• Recreational substance use within past 30 days

Inclusion criteria for healthy control arm:

• = 18 years of age AND age within 5 years of a participant in the TS arm of same biological sex (for purposes of age- and sex-matching)

• Ability to complete survey instruments

• English fluency (given that all scales are validated in English)

Exclusion criteria for healthy control arm:

• Any neurologic or psychiatric diagnoses

• History of tics

• Use of any psychotropic medications within the past 30 days

• Recreational substance use within past 30 days

Related Conditions & MeSH terms

• Hypersensitivity
• Sensation Disorders
• Sensory Disorders
• Syndrome
• Tics
• Tourette Syndrome

Intervention

Diagnostic Test:
• Electroencephalogram (EEG) testing procedure
EEG testing procedure, comprised of somatosensory and auditory event-related potential paradigms, as well as resting state EEG
• Autonomic function testing procedure
Autonomic function testing procedure, comprised of electrodes to determine heart rate variability and electrodermal activity (EDA)

Locations

Country	Name	City	State
United States	Vanderbilt University Medical Center	Nashville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Vanderbilt University Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Network oscillations in response to sensory stimuli	Neural activity captured on EEG can be spectrally decomposed into various frequency constituencies. Neural activity in the gamma frequency range, so-called gamma band oscillations (GBOs), are associated with sensory processing and integration and are postulated to underlie sensory phenomena in TS.	Baseline
Primary	Heart rate variability	Change beat-to-beat variability in heart rate	Baseline
Primary	Electrodermal activity in response to sensory stimuli	Sweat response changes within 1-3 seconds of non-aversive sensory stimulus	Baseline
Secondary	Premonitory Urge to Tic Scale (PUTS)	Validated self-report questionnaire comprised of 9 items assessing character and severity of premonitory urges. Scale range: 9 (least affected) - 36 (most affected)	Within 1 week of baseline
Secondary	Yale Global Tic Severity Scale (YGTSS)	Validated, gold-standard clinician-administered tic assessment scale, comprised of 11 items. Scale range: 0 (best) - 100 (worst)	Within 1 week of baseline
Secondary	Dimensional Obsessive Compulsive Scale (DOCS)	Validated self-report questionnaire assessing severity of obsessive and compulsive symptoms, comprised of 20 items. Scale range 0 (least affected) - 80 (most affected)	Within 1 week of baseline
Secondary	Adult ADHD Self-Report Screening Scale	Validated self-report scale, developed since release of Diagnostic and Statistical Manual-V, comprised of 6 items. Scale range 0 (least affected) - 24 (most affected)	Within 1 week of baseline
Secondary	Generalized Anxiety Disorder 7 (GAD-7)	Validated self-report scale assessing presence and extent of anxiety, comprised of 7 items. Scale range 0 (least affected) - 21 (most affected)	Within 1 week of baseline
Secondary	Patient Health Questionnaire 9 (PHQ-9)	Validated self-report scale assessing presence and extent of depression, comprised of 9 items. Scale range 0 (least affected) - 27 (most affected)	Within 1 week of baseline
Secondary	Sensory Gating Inventory (SGI)	Validated self-report questionnaire assessing sensory hypo- or hyper-sensitivity, comprised of 36 items. The 4 sub-scales include Perceptual Modulation, Distractability, Over-Inclusion, and Fatigue and Stress Vulnerability. Total scale range 0 (least affected) - 180 (most affected)	Within 1 week of baseline
Secondary	Sensory Perception Quotient (SPQ)	Validated self-report questionnaire assessing sensory hypo- or hyper-sensitivity, comprised of 35 items. Scale range 0 (highest sensory sensitivity) - 105 (lowest sensory sensitivity).	Within 1 week of baseline
Secondary	Gilles de la Tourette Syndrome - Quality of Life Scale (GTS-QOL)	Validated self-report questionnaire assessing health-related quality of life for patients with Tourette syndrome, comprised of 27 items. Scale range 0 (best quality of life) - 108 (worst quality of life)	Within 1 week of baseline
Secondary	Patient Reported Outcomes Measurement Information System (PROMIS) Sleep-Related Impairment	Validated self-report questionnaire to measures sleep-related impairments, consisting of 8 items. Scale range 0 - 100 (t-score scaled with lower values indicating less impairment).	Within 1 week of baseline
Secondary	Multidimensional Assessment of Interoceptive Awareness-2 (MAIA-2)	Validated self-report questionnaire assessing interoceptive sensibility, comprised of 37 items. Each scale item is a statement to which respondents must select "never" (0) to "always" (5) on a six-point Likert scale. No total MAIA-2 score exists. Rather, individual scale items belong to one of eight MAIA-2 subscales. For each subscale, higher score signifies more of that construct.	Within 1 week of baseline
Secondary	Body Perception Questionnaire - Short Form (BPQ-SF)	Validated self-report questionnaire assessing interoceptive sensibility, comprised of 46 items total, divided into 3 sections: Body Awareness (raw total score 26-130), Supradiaphragmatic Reactivity (raw total score 15-69), and Subdiaphragmatic Reactivity (raw total score 6-28). Raw scores are converted to T-scores. Higher raw and T-scores indicate greater maladaptive body awareness.	Within 1 week of baseline